Patents by Inventor Inger Byrjalsen

Inger Byrjalsen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ASSESSMENT OF PROTEIN DEGRADATION BY MEASUREMENT OF ISOMERISED NEO-EPITOPE CONTAINING FRAGMENTS
    Publication number: 20110256639
    Abstract: A method of immunoassay for fragments of a protein such as type II collagen in a biological sample detects fragments having a first epitope containing an isomerised amino acid residue and a second epitope generated by cleavage of the protein by the use of respective antibodies binding each of the two epitopes.
    Type: Application
    Filed: November 11, 2009
    Publication date: October 20, 2011
    Applicant: Nordic Biosciences A/S
    Inventors: Diana J. Leeming, Inger Byrjalsen, Per Qvist, Morten A. Karsdal
  • ASSESSMENT OF PROTEIN DEGRADATION BY MEASUREMENT OF COLLAGEN FRAGMENTS
    Publication number: 20110244483
    Abstract: A method of assay measuring in a biological sample fragments of a protein that contain an N-terminal neo-epitope and a C-terminal neo-epitope, each generated by protease cleavage of said protein, comprises binding the N-terminal neo-epitope with a first specific antibody and binding the C-terminal neo-epitope with a second specific antibody, and detecting the extent of dual binding of said antibodies.
    Type: Application
    Filed: November 11, 2009
    Publication date: October 6, 2011
    Inventors: Diana J. Leeming, Inger Byrjalsen, Per Qvist, Morten A. Karsdal
  • ASSESSMENT OF SUBCHONDRAL BONE REMODELLING BY MEASURING CATHEPSIN K FRAGMENTS OF COLLAGEN TYPE II
    Publication number: 20110244482
    Abstract: A method of assay to determine the extent of collagen type II resorption activity comprising measuring the level of fragments of collagen type II that contain a cathepsin K generated neo-epitope not shared by collagen type I by binding the neo-epitope with an antibody specific for the neo-epitope and detecting the level of binding of said binding partner.
    Type: Application
    Filed: November 11, 2009
    Publication date: October 6, 2011
    Inventors: Diana J. Leeming, Inger Byrjalsen, Per Qvist, Morten A. Karsdal
  • Biochemical markers of the human endometrium
    Patent number: 7655471
    Abstract: Endometrium secreted polypeptides are assayed in body fluids to determine the presence of polypeptides of specified pI and MW values that have been found to be regulated in body fluids according to the status of the endometrium, or the presence of hyperplasia or adenocarcinoma.
    Type: Grant
    Filed: January 17, 2003
    Date of Patent: February 2, 2010
    Assignee: Drugmode APS
    Inventors: Inger Byrjalsen, Peter M. Larsen, Stephen J. Fey
  • Biochemical markers of the human endometrium
    Publication number: 20060115812
    Abstract: Endometrium secreted polypeptides are assayed in body fluids to determine the presence of polypeptides of specified pI and MW values that have been found to be regulated in body fluids according to the status of the endometrium, or the presence of hyperplasia or adenocarcinoma.
    Type: Application
    Filed: January 17, 2003
    Publication date: June 1, 2006
    Inventors: Inger Byrjalsen, Peter Larsen, Stephen Fey